| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 26 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 26 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 26 |
| 3 | ETOPOSIDE | 19 |
| 4 | CISPLATIN | 18 |
| 5 | DOXORUBICIN | 18 |
| 6 | RITUXIMAB | 18 |
| 7 | METHOTREXATE SODIUM | 16 |
| 8 | METHOTREXATE | 14 |
| 9 | MELPHALAN HYDROCHLORIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUBICIN HYDROCHLORIDE | 3 | 0.0026 |
| 1 | ARSENIC TRIOXIDE | 5 | 0.0022 |
| 2 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 3 | TOPOTECAN | 9 | 0.0015 |
| 4 | ELIGLUSTAT | 2 | 0.0012 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 7 | 0.0011 |
| 6 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 1 | 0.0010 |
| 7 | TRETINOIN | 6 | 0.0007 |
| 8 | THIOTEPA | 7 | 0.0007 |
| 9 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 27 |
| 1 | Platinum-based Drug [EPC] | 21 |
| 2 | Topoisomerase Inhibitor [EPC] | 20 |
| 3 | Corticosteroid [EPC] | 19 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 18 |
| 5 | Mood Stabilizer [EPC] | 16 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 15 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 8 | Anti-epileptic Agent [EPC] | 11 |
| 9 | Kinase Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glucosylceramide Synthase Inhibitor [EPC] | 2 | 0.0007 |
| 1 | Oxytocic [EPC] | 1 | 0.0003 |
| 2 | Topoisomerase Inhibitor [EPC] | 20 | 0.0003 |
| 3 | BCL-2 Inhibitor [EPC] | 10 | 0.0002 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 27 | 0.0001 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |